EpilepsyGTx
PrivateLast Round
Series A
Dec 10, 2025
Total Funding Raised
$43M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
EpilepsyGTx is a biotechnology company developing cutting-edge gene therapies to treat focal refractory epilepsy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EpilepsyGTx Comparables
Compare EpilepsyGTx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Latus Bio | 84% | |
| Capsida Biotherapeutics | 81% | |
| Kriya Therapeutics | 80% | |
EpilepsyGTx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 10, 2025 | ||||
| Seed | Jun 24, 2024 |
Key People
Founding team and executive leadership
EpilepsyGTx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| XGEN Venture | Series A |
| British Business Bank | Series A |
| UCL Business | Seed |
| Albion Capital | Seed |
| Zcube | Seed |
| Health Technology Holding | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
Professor Dimitri Kullmann appointed as the new CSO.
EpilepsyGTx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EpilepsyGTx's valuation, stock price, and market status.